Optimizing electronic health record prompts with behavioral economics to improve prescribing for older adults

优化电子健康记录促进行为经济学改善老年人处方

基本信息

  • 批准号:
    10008009
  • 负责人:
  • 金额:
    $ 72.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines, antipsychotics, anticholinergics, and sedative hypnotics are four key drug classes frequently implicated in adverse health consequences for vulnerable older adults, such as confusion or sedation, leading to hospitalizations, falls, and fractures. Fortunately, most of these consequences are preventable. Physicians’ lack of awareness of alternatives, ambiguous practice guidelines, and perceived pressure from patients or caregivers are among the reasons why these drugs are used more than might be optimal. Reducing inappropriate use of these drugs may be achieved through decision support tools for providers that are embedded in electronic health record (EHR) systems. While EHR strategies are widely used to support the informational needs of providers, these tools have demonstrated only modest effectiveness at improving prescribing. The effectiveness of these tools could be enhanced by leveraging principles of behavioral economics and related sciences. In specific, three behavioral economic principles, such as salience effects, social norming, and default bias, have successfully changed behavior in other settings but have had very limited application in EHRs and, more specifically, for prescribing in older adults. To this end, we propose three cluster randomized controlled trials of novel EHR decision support tools that seek to reduce inappropriate prescribing for these drug classes and their associated adverse drug events and health outcomes. This proposal builds on many years of research by our group on interventions to engage providers and patients in clinical-decision making, behavior change, and evaluating novel interventions in real- world delivery systems. The EHR decision support tools will be designed using promising behavioral economic principles such as salience effects, social norming, and default bias. The specific aims of this study are to: (1) design and pilot test multiple EHR decision support tools constructed using behavioral economics principles; (2) rapidly identify the potential effectiveness of numerous EHR tools at reducing inappropriate prescribing using a novel randomized adaptive design; (3) examine whether these most potentially promising EHR tools from Aim 2 reduce inappropriate prescribing and adverse drug events when using a randomized parallel group trial; and (4) evaluate the effectiveness of the EHR tools in a different clinical environment. Using rigorous randomized designs, we have proposed a pragmatic and scalable approach to optimizing and evaluating EHR tools aimed at provider behavior change for prescribing for older adults. We will also be able to rigorously test a large number of EHR tools as well as replicate and validate the effectiveness of the best performing tools in a different healthcare system. The expected overall impact of this innovative proposal is that it will fundamentally advance how behavioral economics can be used to optimize decision support to reduce inappropriate prescribing and ultimately improve patient outcomes.
给老年人开可能不安全的药物极为普遍;苯二氮卓类,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Niteesh K Choudhry其他文献

Niteesh K Choudhry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Niteesh K Choudhry', 18)}}的其他基金

Analysis and visualization of longitudinal assessments of clinical, functional and psychosocial state of AD patients from the Massachusetts home care program
对马萨诸塞州家庭护理项目 AD 患者的临床、功能和心理社会状态的纵向评估进行分析和可视化
  • 批准号:
    10756631
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10491782
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Facilitating and Supporting Industry Engagement
促进和支持行业参与
  • 批准号:
    10837221
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Al-Supported In-Home Brain Assessments for Older Adults and Persons with Alzheimer's Disease
Al 支持的针对老年人和阿尔茨海默病患者的家庭大脑评估
  • 批准号:
    10755044
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Validating novel sleep sensors and devices in older adults with Alzheimer's disease
在患有阿尔茨海默病的老年人中验证新型睡眠传感器和设备
  • 批准号:
    10756674
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Creation of a technology-ready cohort for patients with Alzheimer's disease and related dementias and their caregivers
为阿尔茨海默病和相关痴呆症患者及其护理人员创建技术就绪队列
  • 批准号:
    10782660
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10675671
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10274688
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Passive Monitoring of Walking Cadence as a Novel Tool for Aging and Cognitive Health Assessment
步行节奏的被动监测作为衰老和认知健康评估的新工具
  • 批准号:
    10755452
  • 财政年份:
    2021
  • 资助金额:
    $ 72.13万
  • 项目类别:
Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension
利用电子健康记录工具减少未受控制的高血压患者的健康差异
  • 批准号:
    10542667
  • 财政年份:
    2020
  • 资助金额:
    $ 72.13万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 72.13万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 72.13万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 72.13万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 72.13万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 72.13万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 72.13万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 72.13万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 72.13万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 72.13万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 72.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了